AMBER KOONCE: Open Payments
NPI 1760839328 · GRANTS PASS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 19 payments from 6 companies in 2025. Trend: 2023 $439 · 2024 $128 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $123 |
| Biogen, Inc. | 5 | $115 |
| Astellas Pharma US Inc | 5 | $84 |
| Organon LLC | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $17 |
Products named: ZURZUVAE, LILETTA, Veozah, QULIPTA, NEXPLANON, Lynkuet, Phexxi.
Industry payments across OR — which companies pay providers there.
